According to Zen Score, the 3 best medical care facility stocks to buy right now are:
1. Cross Country Healthcare (NASDAQ:CCRN)
Cross Country Healthcare (NASDAQ:CCRN) is the top medical care facility stock with a Zen Score of 61, which is 32 points higher than the medical care facility industry average of 29. It passed 19 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -20.27% over the past year, underperforming other medical care facility stocks by -25 percentage points.
Cross Country Healthcare has an average 1 year
price target of $20.80, an upside of 16.2% from Cross Country Healthcare's current stock price of $17.90.
Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Cross Country Healthcare, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Astrana Health (NASDAQ:ASTH)
Astrana Health (NASDAQ:ASTH) is the second best medical care facility stock with a Zen Score of 54, which is 25 points higher than the medical care facility industry average of 29. It passed 17 out of 33 due diligence checks and has strong fundamentals. Astrana Health has seen its stock return 4.02% over the past year, underperforming other medical care facility stocks by -1 percentage points.
Astrana Health has an average 1 year
price target of $48.00, an upside of 28.86% from Astrana Health's current stock price of $37.25.
Astrana Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Astrana Health, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
3. Docgo (NASDAQ:DCGO)
Docgo (NASDAQ:DCGO) is the third best medical care facility stock with a Zen Score of 52, which is 23 points higher than the medical care facility industry average of 29. It passed 17 out of 33 due diligence checks and has strong fundamentals. Docgo has seen its stock lose -58.76% over the past year, underperforming other medical care facility stocks by -64 percentage points.
Docgo has an average 1 year
price target of $9.50, an upside of 180.24% from Docgo's current stock price of $3.39.
Docgo stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Docgo, 80% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.